| Year |
Citation |
Score |
| 2010 |
Panner A, Crane CA, Weng C, Feletti A, Fang S, Parsa AT, Pieper RO. Ubiquitin-specific protease 8 links the PTEN-Akt-AIP4 pathway to the control of FLIPS stability and TRAIL sensitivity in glioblastoma multiforme. Cancer Research. 70: 5046-53. PMID 20484045 DOI: 10.1158/0008-5472.Can-09-3979 |
0.421 |
|
| 2009 |
Panner A, Crane CA, Weng C, Feletti A, Parsa AT, Pieper RO. A novel PTEN-dependent link to ubiquitination controls FLIPS stability and TRAIL sensitivity in glioblastoma multiforme. Cancer Research. 69: 7911-6. PMID 19808964 DOI: 10.1158/0008-5472.Can-09-1287 |
0.448 |
|
| 2009 |
Crane C, Panner A, Pieper RO, Arbiser J, Parsa AT. Honokiol-mediated inhibition of PI3K/mTOR pathway: a potential strategy to overcome immunoresistance in glioma, breast, and prostate carcinoma without impacting T cell function. Journal of Immunotherapy (Hagerstown, Md. : 1997). 32: 585-92. PMID 19483651 DOI: 10.1097/Cji.0B013E3181A8Efe6 |
0.492 |
|
| 2009 |
Crane CA, Panner A, Murray JC, Wilson SP, Xu H, Chen L, Simko JP, Waldman FM, Pieper RO, Parsa AT. PI(3) kinase is associated with a mechanism of immunoresistance in breast and prostate cancer. Oncogene. 28: 306-12. PMID 18850006 DOI: 10.1038/Onc.2008.384 |
0.36 |
|
| 2008 |
Chi JH, Panner A, Cachola K, Crane CA, Murray J, Pieper RO, James CD, Parsa AT. Increased expression of the glioma-associated antigen ARF4L after loss of the tumor suppressor PTEN. Laboratory investigation. Journal of Neurosurgery. 108: 299-303. PMID 18240926 DOI: 10.3171/Jns/2008/108/2/0299 |
0.437 |
|
| 2007 |
Panner A, Murray JC, Berger MS, Pieper RO. Heat shock protein 90alpha recruits FLIPS to the death-inducing signaling complex and contributes to TRAIL resistance in human glioma. Cancer Research. 67: 9482-9. PMID 17909058 DOI: 10.1158/0008-5472.Can-07-0569 |
0.441 |
|
| 2007 |
Parsa AT, Waldron JS, Panner A, Crane CA, Parney IF, Barry JJ, Cachola KE, Murray JC, Tihan T, Jensen MC, Mischel PS, Stokoe D, Pieper RO. Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma. Nature Medicine. 13: 84-8. PMID 17159987 DOI: 10.1038/Nm1517 |
0.425 |
|
| 2006 |
Panner A, Parsa AT, Pieper RO. Use of APO2L/TRAIL with mTOR inhibitors in the treatment of glioblastoma multiforme. Expert Review of Anticancer Therapy. 6: 1313-22. PMID 17020463 DOI: 10.1586/14737140.6.9.1313 |
0.44 |
|
| 2006 |
Panner A, Nakamura JL, Parsa AT, Rodriguez-Viciana P, Berger MS, Stokoe D, Pieper RO. mTOR-independent translational control of the extrinsic cell death pathway by RalA. Molecular and Cellular Biology. 26: 7345-57. PMID 16894031 DOI: 10.1128/Mcb.00126-06 |
0.475 |
|
| 2006 |
Panner A, Wurster RD. T-type calcium channels and tumor proliferation. Cell Calcium. 40: 253-9. PMID 16765439 DOI: 10.1016/J.Ceca.2006.04.029 |
0.513 |
|
| 2006 |
Panner A, Parsa AT, Pieper RO. Translational regulation of TRAIL sensitivity. Cell Cycle (Georgetown, Tex.). 5: 147-50. PMID 16397410 DOI: 10.4161/Cc.5.2.2359 |
0.447 |
|
| 2005 |
Lu F, Chen H, Zhou C, Wu S, Panner A. Is there a role for T-type Ca2+ channel in glioma cell proliferation? (multiple letter) Cell Calcium. 38: 593-595. PMID 16242186 DOI: 10.1016/j.ceca.2005.09.005 |
0.386 |
|
| 2005 |
Panner A, James CD, Berger MS, Pieper RO. mTOR controls FLIPS translation and TRAIL sensitivity in glioblastoma multiforme cells. Molecular and Cellular Biology. 25: 8809-23. PMID 16199861 DOI: 10.1128/Mcb.25.20.8809-8823.2005 |
0.493 |
|
| 2005 |
Panner A, Cribbs LL, Zainelli GM, Origitano TC, Singh S, Wurster RD. Variation of T-type calcium channel protein expression affects cell division of cultured tumor cells. Cell Calcium. 37: 105-19. PMID 15589991 DOI: 10.1016/J.Ceca.2004.07.002 |
0.518 |
|
| 2004 |
Saito R, Bringas JR, Panner A, Tamas M, Pieper RO, Berger MS, Bankiewicz KS. Convection-enhanced delivery of tumor necrosis factor-related apoptosis-inducing ligand with systemic administration of temozolomide prolongs survival in an intracranial glioblastoma xenograft model. Cancer Research. 64: 6858-62. PMID 15466173 DOI: 10.1158/0008-5472.Can-04-1683 |
0.403 |
|
| Show low-probability matches. |